Showing 1–3 of 3 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Evans D, Hirasen K, Ramushu C, Long L, Sinanovic E, et al.
…ltidrug-resistant (MDR)-TB, pre-extensively drug-resistant (pre-XDR)-TB and XDR-TB. Historically, all variations of DR-TB required treatment with second-line drugs which are less effective and more toxic than first-line options, have a longer treatment duration and are more expen…
Fumagalli G, Riccardi N, Catalano G, Ferrarese M, Repossi AC, et al.
…se of transborder pulmonary pre-extensively drug-resistant (pre-XDR)-TB treated in Italy with the bedaquiline-pretomanid-linezolid regimen. Diagnosis and treatment were started in Ukraine, and, after a month of treatment, due to the Russo-Ukrainian war, the patient moved to Italy…
Goswami N, Peddareddy L, Jereb J, Semidey A, Darnall E, et al.
… U.S. FDA approved pretomanid as part of a 6-month all-oral BPaL (bedaquiline, pretomanid, and linezolid) regimen for treating pulmonary extensively drug-resistant (XDR) or treatment-intolerant or nonresponsive multidrug-resistant (MDR) tuberculosis (TB). In the study supporting …